Susan C Garay, MD
Internal Medicine · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Garay’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G73336 · Current
Licensed to practise in California · since 1992 · expires 2027-10-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$122,168
Medicare paid this office $122,168 for 256 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 166 | $57,316 | $159 |
| Return visit (30+ min) | 158 | $23,514 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 136 | $20,819 | $153 |
| Sarscov2 vac 50 mcg/0.5ml im | 24 | $3,632 | $151 |
| Influenza vaccine split virus, preservative free | 27 | $2,209 | $82 |
See all 9 services
| Long return visit (40+ min) | 166 | $57,316 | $159 |
| Return visit (30+ min) | 158 | $23,514 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 136 | $20,819 | $153 |
| Sarscov2 vac 50 mcg/0.5ml im | 24 | $3,632 | $151 |
| Influenza vaccine split virus, preservative free | 27 | $2,209 | $82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 86 | $1,686 | $14 |
| Admn sarscov2 vacc 1 dose | 29 | $1,548 | $52 |
| Administration of influenza virus vaccine | 29 | $1,108 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $282 | $12 |
Who their Medicare patients are
256 Original Medicare patients in 2024. Average age 77 · Women 80% · Health risk score 0.98. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 60% · Coronary heart disease 29% · Cancer 15% · Diabetes 14% · Depression 14% · Atrial fibrillation 13% · Heart failure 12% · Chronic kidney disease 12% · COPD 7% · Dementia 4%.
The office billed $386,221, Medicare allowed $155,657 and paid $122,168; for 1,087 services of 36 kinds; $7,937 of it was for drugs given in the office and $114,231 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 256 | 1,087 | 77 | 0.98 | $386,221 | $122,168 |
| 2023 | 266 | 975 | 76 | 0.94 | $332,320 | $106,231 |
| 2022 | 274 | 1,055 | 76 | 0.97 | $323,954 | $106,206 |
| 2021 | 273 | 933 | 76 | 0.94 | $312,729 | $89,020 |
| 2020 | 249 | 829 | 76 | 1.00 | $259,165 | $59,730 |
| 2019 | 304 | 1,333 | 76 | 1.05 | $387,721 | $91,331 |
| 2018 | 302 | 1,373 | 76 | 1.00 | $367,545 | $91,019 |
| 2017 | 338 | 1,588 | 76 | 1.05 | $366,774 | $97,391 |
| 2016 | 299 | 1,237 | 76 | 0.93 | $319,500 | $89,046 |
| 2015 | 291 | 1,133 | 76 | 0.89 | $276,074 | $87,409 |
| 2014 | 280 | 1,244 | 76 | 0.87 | $237,043 | $75,586 |
| 2013 | 252 | 784 | 76 | 0.91 | $143,089 | $55,135 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Long return visit (40+ min) | 140 | $39,474 | $152 |
| Return visit (30+ min) | 190 | $28,735 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 134 | $20,493 | $153 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,097 | $282 |
| Influenza vaccine split virus, preservative free | 28 | $2,014 | $72 |
| Sarscov2 vac 50 mcg/0.5ml im | 14 | $2,002 | $143 |
| Administration of influenza virus vaccine | 28 | $1,016 | $36 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $1,008 | $50 |
| Admn sarscov2 vacc 1 dose | 17 | $822 | $48 |
| Short return visit (20+ min) | 11 | $768 | $64 |
| Administration of pneumococcal vaccine | 14 | $508 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $296 | $13 |
| Hemoglobin a1c level | 12 | $114 | $10 |
| Automated urinalysis test | 11 | $31 | $2 |
2022: 13 services
| Return visit (30+ min) | 215 | $39,542 | $106 |
| Long return visit (40+ min) | 112 | $30,171 | $166 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 120 | $18,478 | $154 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,059 | $278 |
| Influenza vaccine split virus, preservative free | 37 | $2,533 | $68 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,155 | $196 |
| Short return visit (20+ min) | 25 | $1,736 | $67 |
| Administration of influenza virus vaccine | 39 | $1,407 | $36 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $805 | $50 |
| Administration of pneumococcal vaccine | 16 | $581 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $327 | $14 |
| Hemoglobin a1c level | 15 | $153 | $10 |
| Automated urinalysis test | 15 | $42 | $2 |
2021: 8 services
| Return visit (30+ min) | 217 | $42,666 | $111 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 119 | $18,935 | $159 |
| Long return visit (40+ min) | 61 | $13,281 | $170 |
| Influenza vaccine split virus, preservative free | 49 | $3,198 | $65 |
| Short return visit (20+ min) | 36 | $2,818 | $72 |
| Administration of influenza virus vaccine | 50 | $1,062 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $290 | $13 |
| Hemoglobin a1c level | 12 | $155 | $10 |
2020: 10 services
| Return visit (30+ min) | 189 | $28,320 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 70 | $9,751 | $139 |
| Short return visit (20+ min) | 62 | $4,489 | $68 |
| Long return visit (40+ min) | 28 | $3,514 | $121 |
| Influenza vaccine split virus, preservative free | 53 | $3,220 | $61 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $2,996 | $91 |
| Administration of influenza virus vaccine | 54 | $1,111 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $732 | $21 |
| Blood test, clotting time | 11 | $280 | $4 |
| Hemoglobin a1c level | 13 | $135 | $10 |
2019: 12 services
| Return visit (30+ min) | 251 | $46,151 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 112 | $15,639 | $140 |
| Long return visit (40+ min) | 54 | $8,828 | $128 |
| Influenza vaccine split virus, preservative free | 66 | $3,623 | $55 |
| Pneumococcal vaccine, 13-valent | 16 | $3,346 | $209 |
| Short return visit (20+ min) | 46 | $2,441 | $52 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $1,508 | $22 |
| Administration of influenza virus vaccine | 69 | $1,392 | $20 |
| Hemoglobin a1c level | 43 | $476 | $11 |
| Administration of pneumococcal vaccine | 20 | $404 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $343 | $14 |
| Automated urinalysis test | 16 | $46 | $2 |
2018: 14 services
| Return visit (30+ min) | 258 | $47,175 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 87 | $12,033 | $138 |
| Long return visit (40+ min) | 62 | $11,286 | $125 |
| Influenza vaccine split virus, preservative free | 57 | $2,977 | $52 |
| Pneumococcal vaccine, 13-valent | 13 | $2,552 | $196 |
| Short return visit (20+ min) | 47 | $2,543 | $51 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $1,879 | $19 |
| Administration of influenza virus vaccine | 65 | $1,644 | $25 |
| Blood test, clotting time | 16 | $561 | $5 |
| Administration of pneumococcal vaccine | 18 | $455 | $25 |
| Hemoglobin a1c level | 33 | $447 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $436 | $15 |
| Detection test by immunoassay with direct visual observation for influenza virus | 12 | $195 | $16 |
| Automated urinalysis test | 12 | $33 | $3 |
2017: 14 services
| Return visit (30+ min) | 280 | $53,084 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 97 | $13,386 | $138 |
| Long return visit (40+ min) | 45 | $6,903 | $121 |
| Short return visit (20+ min) | 74 | $4,476 | $53 |
| Pneumococcal vaccine, 13-valent | 20 | $3,696 | $185 |
| Influenza vaccine split virus, preservative free | 56 | $2,691 | $48 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $2,497 | $18 |
| Administration of influenza virus vaccine | 67 | $2,157 | $32 |
| Administration of pneumococcal vaccine | 29 | $934 | $32 |
| Blood test, clotting time | 21 | $792 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $505 | $15 |
| Hemoglobin a1c level | 16 | $235 | $13 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
| Automated urinalysis test | 27 | $97 | $3 |
2016: 10 services
| Return visit (30+ min) | 228 | $44,138 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 102 | $14,141 | $139 |
| Long return visit (40+ min) | 49 | $7,437 | $128 |
| Short return visit (20+ min) | 97 | $6,139 | $54 |
| Pneumococcal vaccine, 13-valent | 32 | $5,608 | $175 |
| Influenza vaccine split virus, preservative free | 50 | $2,079 | $41 |
| Administration of influenza virus vaccine | 60 | $1,957 | $32 |
| Administration of pneumococcal vaccine | 36 | $1,155 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 39 | $627 | $15 |
| Automated urinalysis test | 26 | $96 | $3 |
2015: 11 services
| Return visit (30+ min) | 206 | $42,925 | $92 |
| Pneumococcal vaccine, 13-valent | 74 | $12,200 | $165 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 78 | $10,865 | $139 |
| Short return visit (20+ min) | 106 | $6,683 | $57 |
| Long return visit (40+ min) | 23 | $2,993 | $120 |
| Administration of pneumococcal vaccine | 75 | $2,410 | $32 |
| Administration of influenza virus vaccine | 52 | $1,675 | $32 |
| Influenza vaccine split virus, preservative free | 39 | $1,385 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $343 | $13 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $196 | $18 |
| Automated urinalysis test | 20 | $63 | $3 |
2014: 10 services
| Return visit (30+ min) | 211 | $40,579 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 75 | $10,172 | $136 |
| Short return visit (20+ min) | 110 | $6,904 | $56 |
| Long return visit (40+ min) | 18 | $2,546 | $134 |
| Pneumococcal vaccine, 13-valent | 16 | $2,405 | $150 |
| Administration of influenza virus vaccine | 68 | $1,942 | $28 |
| Influenza vaccine split virus, preservative free | 51 | $1,690 | $32 |
| Administration of pneumococcal vaccine | 26 | $748 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $463 | $14 |
| Automated urinalysis test | 11 | $48 | $3 |
2013: 8 services
| Return visit (30+ min) | 151 | $30,899 | $93 |
| Short return visit (20+ min) | 121 | $10,055 | $61 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $6,714 | $134 |
| Administration of influenza virus vaccine | 41 | $1,115 | $27 |
| Influenza vaccine split virus, preservative free | 27 | $866 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $546 | $17 |
| Administration of vaccine | 13 | $286 | $22 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 11 | $134 | $12 |
Drugs they prescribed that Part D paid
$63,943
Pharmacies billed $63,943 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,652 generic and 172 brand-name prescriptions · $63,943 in drug cost · 35 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 21 | $20,833 | $992 |
| Synthroid | 34 | $3,157 | $93 |
| Atorvastatin | 240 | $2,263 | $9 |
| Levothyroxine | 242 | $2,114 | $9 |
| Olmesartan Medoxomil | 93 | $1,883 | $20 |
See all 31 drugs
| Eliquis | 21 | $20,833 | $992 |
| Synthroid | 34 | $3,157 | $93 |
| Atorvastatin | 240 | $2,263 | $9 |
| Levothyroxine | 242 | $2,114 | $9 |
| Olmesartan Medoxomil | 93 | $1,883 | $20 |
| Rosuvastatin | 210 | $1,586 | $8 |
| Estradiol | 11 | $1,454 | $132 |
| Amlodipine Besylate | 107 | $597 | $6 |
| Losartan | 73 | $594 | $8 |
| Gabapentin | 36 | $573 | $16 |
| Pantoprazole | 26 | $502 | $19 |
| Escitalopram | 34 | $487 | $14 |
| Lisinopril | 65 | $485 | $7 |
| Fluticasone Propionate | 14 | $459 | $33 |
| Diltiazem 24hr Er (Cd) | 11 | $253 | $23 |
| Metoprolol | 16 | $252 | $16 |
| Potassium Chloride | 15 | $250 | $17 |
| Trazodone | 31 | $238 | $8 |
| Omeprazole | 12 | $232 | $19 |
| Metformin | 22 | $227 | $10 |
| Atenolol | 16 | $176 | $11 |
| Zolpidem | 23 | $162 | $7 |
| Fluoxetine | 19 | $145 | $8 |
| Mirtazapine | 14 | $130 | $9 |
| Citalopram Hbr | 14 | $117 | $8 |
| Valacyclovir | 14 | $117 | $8 |
| Hydrochlorothiazide | 20 | $89 | $4 |
| Triamterene-Hydrochlorothiazid | 21 | $60 | $3 |
| Zaleplon | 11 | $50 | $5 |
| Lorazepam | 16 | $43 | $3 |
| Paroxetine | 11 | $20 | $2 |
Year by year
| 2024 | 1,824 | 229 | None | 9% | $63,943 |
| 2023 | 1,671 | 217 | None | None | $67,166 |
| 2022 | 1,670 | 197 | None | None | $63,613 |
| 2021 | 1,629 | 191 | 0% (0) | 11% | $62,573 |
| 2020 | 1,690 | 203 | None | 13% | $71,672 |
| 2019 | 1,897 | 209 | 0% (0) | None | $71,736 |
| 2018 | 2,150 | 216 | 1% (12) | None | $79,571 |
| 2017 | 2,161 | 216 | 1% (18) | None | $66,966 |
| 2016 | 2,229 | 186 | 1% (17) | 15% | $86,308 |
| 2015 | 2,113 | 201 | None | 19% | $89,843 |
| 2014 | 2,085 | 184 | 1% (12) | 23% | $89,846 |
| 2013 | 1,843 | 181 | 2% (34) | None | $87,138 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Eliquis | 16 | $12,597 | $787 |
| Flovent Hfa | 11 | $4,963 | $451 |
| Synthroid | 38 | $3,878 | $102 |
| Levothyroxine | 249 | $3,789 | $15 |
| Atorvastatin | 260 | $2,472 | $10 |
| Rosuvastatin | 144 | $1,693 | $12 |
| Yuvafem | 12 | $1,559 | $130 |
| Olmesartan Medoxomil | 38 | $1,289 | $34 |
| Amlodipine Besylate | 94 | $1,072 | $11 |
| Losartan | 72 | $837 | $12 |
| Gabapentin | 34 | $780 | $23 |
| Lisinopril | 64 | $582 | $9 |
| Trazodone | 30 | $572 | $19 |
| Diltiazem 24hr Er (Cd) | 12 | $517 | $43 |
| Metoprolol | 21 | $516 | $25 |
| Potassium Chloride | 14 | $504 | $36 |
| Atenolol | 14 | $451 | $32 |
| Escitalopram | 21 | $396 | $19 |
| Triamterene-Hydrochlorothiazid | 25 | $381 | $15 |
| Metformin | 24 | $324 | $13 |
| Fluoxetine | 18 | $297 | $16 |
| Zolpidem | 25 | $262 | $10 |
| Omeprazole | 19 | $181 | $10 |
| Citalopram Hbr | 16 | $177 | $11 |
| Pantoprazole | 24 | $162 | $7 |
| Amoxicillin-Clavulanate Potass | 14 | $112 | $8 |
| Allopurinol | 12 | $102 | $8 |
| Sertraline | 15 | $77 | $5 |
| Paroxetine | 13 | $49 | $4 |
| Hydrochlorothiazide | 18 | $30 | $2 |
2022: 34 drugs
| Eliquis | 15 | $12,939 | $863 |
| Flovent Diskus | 16 | $4,695 | $293 |
| Levothyroxine | 234 | $3,811 | $16 |
| Synthroid | 37 | $3,270 | $88 |
| Atorvastatin | 268 | $2,869 | $11 |
| Rosuvastatin | 110 | $1,697 | $15 |
| Olmesartan Medoxomil | 34 | $1,025 | $30 |
| Losartan | 87 | $837 | $10 |
| Diltiazem 24hr Er (Cd) | 13 | $786 | $60 |
| Gabapentin | 23 | $605 | $26 |
| Potassium Chloride | 16 | $562 | $35 |
| Amlodipine Besylate | 82 | $498 | $6 |
| Escitalopram | 33 | $476 | $14 |
| Lisinopril | 74 | $448 | $6 |
| Pantoprazole | 24 | $444 | $19 |
| Metoprolol | 18 | $444 | $25 |
| Metformin | 39 | $423 | $11 |
| Triamterene-Hydrochlorothiazid | 17 | $287 | $17 |
| Allopurinol | 15 | $282 | $19 |
| Omeprazole | 20 | $257 | $13 |
| Atenolol | 14 | $252 | $18 |
| Zolpidem | 22 | $217 | $10 |
| Warfarin | 13 | $194 | $15 |
| Zaleplon | 13 | $190 | $15 |
| Nitrofurantoin Mono-Macro | 13 | $178 | $14 |
| Trazodone | 12 | $167 | $14 |
| Valacyclovir | 19 | $156 | $8 |
| Citalopram Hbr | 14 | $139 | $10 |
| Fluoxetine | 11 | $125 | $11 |
| Hydrochlorothiazide | 23 | $113 | $5 |
| Sertraline | 17 | $109 | $6 |
| Pravastatin | 14 | $90 | $6 |
| Simvastatin | 16 | $80 | $5 |
| Paroxetine | 12 | $48 | $4 |
2021: 29 drugs
| Eliquis | 13 | $13,229 | $1,018 |
| Levothyroxine | 233 | $4,636 | $20 |
| Atorvastatin | 270 | $3,999 | $15 |
| Rosuvastatin | 104 | $3,503 | $34 |
| Synthroid | 32 | $3,314 | $104 |
| Losartan | 83 | $1,056 | $13 |
| Potassium Chloride | 18 | $830 | $46 |
| Gabapentin | 24 | $769 | $32 |
| Pantoprazole | 12 | $671 | $56 |
| Olmesartan Medoxomil | 28 | $632 | $23 |
| Amlodipine Besylate | 75 | $547 | $7 |
| Lisinopril | 80 | $541 | $7 |
| Escitalopram | 29 | $445 | $15 |
| Metformin | 44 | $419 | $10 |
| Allopurinol | 16 | $404 | $25 |
| Metoprolol | 19 | $344 | $18 |
| Omeprazole | 25 | $330 | $13 |
| Atenolol | 18 | $296 | $16 |
| Citalopram Hbr | 22 | $246 | $11 |
| Zaleplon | 12 | $190 | $16 |
| Zolpidem | 28 | $188 | $7 |
| Triamterene-Hydrochlorothiazid | 17 | $188 | $11 |
| Pravastatin | 12 | $180 | $15 |
| Sertraline | 25 | $178 | $7 |
| Duloxetine | 13 | $164 | $13 |
| Warfarin | 14 | $149 | $11 |
| Hydrochlorothiazide | 28 | $142 | $5 |
| Simvastatin | 19 | $108 | $6 |
| Acyclovir | 12 | $94 | $8 |
2020: 31 drugs
| Eliquis | 11 | $9,354 | $850 |
| Rosuvastatin | 89 | $5,251 | $59 |
| Levothyroxine | 228 | $4,801 | $21 |
| Atorvastatin | 253 | $4,491 | $18 |
| Synthroid | 30 | $3,274 | $109 |
| Potassium Chloride | 27 | $1,107 | $41 |
| Pantoprazole | 18 | $999 | $56 |
| Losartan | 88 | $935 | $11 |
| Metoprolol | 28 | $801 | $29 |
| Lisinopril | 91 | $694 | $8 |
| Amlodipine Besylate | 79 | $617 | $8 |
| Omeprazole | 40 | $557 | $14 |
| Escitalopram | 28 | $505 | $18 |
| Triamterene-Hydrochlorothiazid | 25 | $410 | $16 |
| Pravastatin | 15 | $402 | $27 |
| Gabapentin | 23 | $377 | $16 |
| Allopurinol | 15 | $339 | $23 |
| Metformin | 35 | $315 | $9 |
| Montelukast | 13 | $308 | $24 |
| Olmesartan Medoxomil | 12 | $305 | $25 |
| Simvastatin | 19 | $295 | $16 |
| Acyclovir | 11 | $250 | $23 |
| Atenolol | 17 | $207 | $12 |
| Sertraline | 25 | $189 | $8 |
| Hydrochlorothiazide | 35 | $187 | $5 |
| Citalopram Hbr | 23 | $182 | $8 |
| Zaleplon | 17 | $182 | $11 |
| Zolpidem | 29 | $145 | $5 |
| Warfarin | 11 | $131 | $12 |
| Fluoxetine | 11 | $118 | $11 |
| Cephalexin | 11 | $63 | $6 |
2019: 36 drugs
| Atorvastatin | 302 | $5,557 | $18 |
| Prempro | 14 | $4,124 | $295 |
| Rosuvastatin | 83 | $4,093 | $49 |
| Levothyroxine | 194 | $3,867 | $20 |
| Synthroid | 33 | $2,793 | $85 |
| Omeprazole | 47 | $1,632 | $35 |
| Potassium Chloride | 22 | $1,194 | $54 |
| Metoprolol | 25 | $1,098 | $44 |
| Escitalopram | 44 | $826 | $19 |
| Losartan | 80 | $782 | $10 |
| Pravastatin | 27 | $782 | $29 |
| Olmesartan Medoxomil | 20 | $662 | $33 |
| Pantoprazole | 15 | $647 | $43 |
| Amlodipine Besylate | 84 | $596 | $7 |
| Lisinopril | 87 | $563 | $6 |
| Triamterene-Hydrochlorothiazid | 42 | $550 | $13 |
| Cartia Xt | 15 | $464 | $31 |
| Irbesartan | 12 | $427 | $36 |
| Metformin | 39 | $413 | $11 |
| Losartan-Hydrochlorothiazide | 17 | $410 | $24 |
| Allopurinol | 20 | $385 | $19 |
| Tamsulosin | 13 | $346 | $27 |
| Gabapentin | 19 | $308 | $16 |
| Hydrochlorothiazide | 36 | $290 | $8 |
| Simvastatin | 25 | $275 | $11 |
| Warfarin | 22 | $266 | $12 |
| Atenolol | 23 | $204 | $9 |
| Montelukast | 11 | $203 | $18 |
| Zolpidem | 35 | $185 | $5 |
| Fluticasone Propionate | 12 | $185 | $15 |
| Citalopram Hbr | 30 | $167 | $6 |
| Zaleplon | 12 | $146 | $12 |
| Sertraline | 18 | $139 | $8 |
| Azithromycin | 20 | $113 | $6 |
| Amoxicillin-Clavulanate Potass | 11 | $92 | $8 |
| Spironolactone | 11 | $62 | $6 |
2018: 43 drugs
| Atorvastatin | 274 | $4,714 | $17 |
| Levothyroxine | 210 | $4,216 | $20 |
| Diltiazem 24hr Er (Cd) | 27 | $2,986 | $111 |
| Rosuvastatin | 82 | $2,521 | $31 |
| Synthroid | 30 | $2,395 | $80 |
| Omeprazole | 54 | $2,127 | $39 |
| Metoprolol | 42 | $1,315 | $31 |
| Pravastatin | 40 | $1,106 | $28 |
| Losartan | 93 | $881 | $9 |
| Amlodipine Besylate | 123 | $845 | $7 |
| Olmesartan Medoxomil | 16 | $759 | $47 |
| Cartia Xt | 22 | $730 | $33 |
| Lisinopril | 95 | $668 | $7 |
| Potassium Chloride | 14 | $651 | $46 |
| Montelukast | 33 | $633 | $19 |
| Escitalopram | 26 | $596 | $23 |
| Metformin | 51 | $549 | $11 |
| Gabapentin | 33 | $526 | $16 |
| Triamterene-Hydrochlorothiazid | 38 | $476 | $13 |
| Simvastatin | 45 | $418 | $9 |
| Clopidogrel | 18 | $414 | $23 |
| Pantoprazole | 16 | $396 | $25 |
| Warfarin | 19 | $381 | $20 |
| Allopurinol | 16 | $374 | $23 |
| Valsartan | 20 | $320 | $16 |
| Rabeprazole | 11 | $305 | $28 |
| Benazepril | 24 | $304 | $13 |
| Zolpidem | 40 | $291 | $7 |
| Sertraline | 37 | $257 | $7 |
| Fluoxetine | 13 | $252 | $19 |
| Finasteride | 12 | $249 | $21 |
| Alendronate | 13 | $216 | $17 |
| Zaleplon | 12 | $213 | $18 |
| Citalopram Hbr | 40 | $213 | $5 |
| Losartan-Hydrochlorothiazide | 15 | $157 | $10 |
| Terazosin | 11 | $149 | $14 |
| Atenolol | 23 | $139 | $6 |
| Hydrocodone-Acetaminophen | 11 | $97 | $9 |
| Azithromycin | 16 | $94 | $6 |
| Quinapril | 11 | $89 | $8 |
| Spironolactone | 12 | $89 | $7 |
| Hydrochlorothiazide | 22 | $81 | $4 |
| Furosemide | 14 | $61 | $4 |
2017: 47 drugs
| Levothyroxine | 228 | $4,594 | $20 |
| Atorvastatin | 200 | $3,398 | $17 |
| Rosuvastatin | 63 | $2,227 | $35 |
| Synthroid | 26 | $2,189 | $84 |
| Omeprazole | 54 | $1,591 | $29 |
| Metoprolol | 64 | $1,380 | $22 |
| Pravastatin | 44 | $1,095 | $25 |
| Gabapentin | 51 | $863 | $17 |
| Lisinopril | 132 | $808 | $6 |
| Amlodipine Besylate | 96 | $736 | $8 |
| Toprol Xl | 11 | $704 | $64 |
| Potassium Chloride | 22 | $647 | $29 |
| Losartan | 66 | $612 | $9 |
| Zolpidem | 44 | $605 | $14 |
| Warfarin | 32 | $533 | $17 |
| Triamterene-Hydrochlorothiazid | 34 | $430 | $13 |
| Valsartan | 34 | $387 | $11 |
| Rabeprazole | 13 | $349 | $27 |
| Metformin | 44 | $344 | $8 |
| Montelukast | 20 | $342 | $17 |
| Simvastatin | 49 | $335 | $7 |
| Clopidogrel | 22 | $327 | $15 |
| Cartia Xt | 16 | $305 | $19 |
| Diltiazem 24hr Er | 11 | $294 | $27 |
| Pantoprazole | 11 | $244 | $22 |
| Sertraline | 35 | $243 | $7 |
| Alendronate | 16 | $242 | $15 |
| Atenolol | 43 | $238 | $6 |
| Finasteride | 17 | $233 | $14 |
| Escitalopram | 24 | $226 | $9 |
| Amoxicillin-Clavulanate Potass | 23 | $214 | $9 |
| Citalopram Hbr | 22 | $187 | $8 |
| Benazepril | 37 | $183 | $5 |
| Fluticasone Propionate | 14 | $172 | $12 |
| Nitrofurantoin Mono-Macro | 11 | $152 | $14 |
| Hydrocodone-Acetaminophen | 13 | $146 | $11 |
| Clonidine | 12 | $137 | $11 |
| Azithromycin | 27 | $134 | $5 |
| Fluoxetine | 14 | $125 | $9 |
| Irbesartan | 11 | $116 | $11 |
| Hydrochlorothiazide | 38 | $110 | $3 |
| Cephalexin | 14 | $85 | $6 |
| Quinapril | 11 | $85 | $8 |
| Amoxicillin | 13 | $51 | $4 |
| Paroxetine | 14 | $50 | $4 |
| Furosemide | 14 | $47 | $3 |
| Carvedilol | 11 | $43 | $4 |
2016: 49 drugs
| Crestor | 34 | $10,226 | $301 |
| Levothyroxine | 275 | $5,132 | $19 |
| Xarelto | 12 | $4,246 | $354 |
| Atorvastatin | 191 | $3,274 | $17 |
| Synthroid | 16 | $1,753 | $110 |
| Omeprazole | 46 | $1,661 | $36 |
| Metoprolol | 53 | $1,600 | $30 |
| Valsartan | 23 | $1,309 | $57 |
| Zolpidem | 54 | $1,234 | $23 |
| Celecoxib | 15 | $1,167 | $78 |
| Rosuvastatin | 18 | $1,096 | $61 |
| Amlodipine Besylate | 116 | $975 | $8 |
| Pravastatin | 35 | $868 | $25 |
| Lisinopril | 135 | $800 | $6 |
| Potassium Chloride | 26 | $659 | $25 |
| Losartan | 69 | $598 | $9 |
| Gabapentin | 40 | $573 | $14 |
| Clopidogrel | 31 | $560 | $18 |
| Mexiletine | 12 | $514 | $43 |
| Simvastatin | 76 | $493 | $6 |
| Montelukast | 19 | $484 | $25 |
| Pantoprazole | 18 | $472 | $26 |
| Warfarin | 24 | $467 | $19 |
| Metformin | 45 | $466 | $10 |
| Triamterene-Hydrochlorothiazid | 38 | $424 | $11 |
| Rabeprazole | 12 | $348 | $29 |
| Citalopram Hbr | 25 | $327 | $13 |
| Valsartan-Hydrochlorothiazide | 13 | $321 | $25 |
| Cartia Xt | 12 | $318 | $27 |
| Finasteride | 18 | $314 | $17 |
| Atenolol | 43 | $304 | $7 |
| Hydrocodone-Acetaminophen | 17 | $269 | $16 |
| Allopurinol | 15 | $244 | $16 |
| Escitalopram | 23 | $243 | $11 |
| Quinapril | 12 | $230 | $19 |
| Hydrochlorothiazide | 72 | $221 | $3 |
| Irbesartan | 14 | $217 | $15 |
| Nitrofurantoin Mono-Macro | 11 | $216 | $20 |
| Alendronate | 16 | $193 | $12 |
| Lisinopril-Hydrochlorothiazide | 20 | $189 | $9 |
| Sertraline | 18 | $189 | $10 |
| Glipizide Xl | 17 | $186 | $11 |
| Diltiazem 24hr Cd | 12 | $178 | $15 |
| Zaleplon | 12 | $157 | $13 |
| Cephalexin | 13 | $152 | $12 |
| Ciprofloxacin | 12 | $148 | $12 |
| Azithromycin | 20 | $133 | $7 |
| Metoprolol | 11 | $93 | $8 |
| Amoxicillin | 15 | $52 | $3 |
2015: 46 drugs
| Crestor | 48 | $15,199 | $317 |
| Benicar | 19 | $4,906 | $258 |
| Levothyroxine | 197 | $4,295 | $22 |
| Xarelto | 12 | $3,898 | $325 |
| Atorvastatin | 167 | $3,111 | $19 |
| Synthroid | 26 | $2,154 | $83 |
| Vagifem | 12 | $2,108 | $176 |
| Omeprazole | 39 | $1,837 | $47 |
| Diltiazem 24hr Cd | 26 | $1,559 | $60 |
| Valsartan | 15 | $1,521 | $101 |
| Norvasc | 12 | $1,401 | $117 |
| Zolpidem | 60 | $1,337 | $22 |
| Pravastatin | 36 | $1,157 | $32 |
| Amlodipine Besylate | 103 | $1,129 | $11 |
| Fenofibrate | 19 | $1,055 | $56 |
| Duloxetine | 21 | $1,027 | $49 |
| Metoprolol | 34 | $1,025 | $30 |
| Losartan | 64 | $767 | $12 |
| Lisinopril | 154 | $763 | $5 |
| Gabapentin | 46 | $679 | $15 |
| Simvastatin | 88 | $658 | $7 |
| Warfarin | 21 | $530 | $25 |
| Clopidogrel | 30 | $439 | $15 |
| Mexiletine | 14 | $437 | $31 |
| Metformin | 38 | $426 | $11 |
| Montelukast | 12 | $394 | $33 |
| Potassium Chloride | 19 | $360 | $19 |
| Quinapril | 14 | $297 | $21 |
| Hydrochlorothiazide | 71 | $293 | $4 |
| Pantoprazole | 19 | $283 | $15 |
| Allopurinol | 22 | $280 | $13 |
| Triamterene-Hydrochlorothiazid | 31 | $264 | $9 |
| Atenolol | 38 | $262 | $7 |
| Sertraline | 25 | $250 | $10 |
| Furosemide | 24 | $220 | $9 |
| Lovastatin | 19 | $199 | $10 |
| Zaleplon | 13 | $198 | $15 |
| Finasteride | 19 | $193 | $10 |
| Escitalopram | 15 | $179 | $12 |
| Lisinopril-Hydrochlorothiazide | 24 | $170 | $7 |
| Fluticasone Propionate | 15 | $160 | $11 |
| Spironolactone | 13 | $154 | $12 |
| Fluoxetine | 17 | $139 | $8 |
| Ciprofloxacin | 23 | $137 | $6 |
| Azithromycin | 16 | $118 | $7 |
| Citalopram Hbr | 16 | $113 | $7 |
2014: 48 drugs
| Crestor | 50 | $12,549 | $251 |
| Diovan | 35 | $9,397 | $268 |
| Levothyroxine | 213 | $3,687 | $17 |
| Atorvastatin | 157 | $3,385 | $22 |
| Benicar | 11 | $3,205 | $291 |
| Omeprazole | 44 | $2,431 | $55 |
| Metoprolol | 60 | $2,349 | $39 |
| Fenofibrate | 17 | $1,457 | $86 |
| Rivastigmine | 11 | $1,451 | $132 |
| Duloxetine | 11 | $1,433 | $130 |
| Gabapentin | 28 | $1,256 | $45 |
| Norvasc | 12 | $1,223 | $102 |
| Pravastatin | 24 | $1,223 | $51 |
| Lisinopril | 164 | $1,186 | $7 |
| Oxybutynin Chloride Er | 12 | $1,166 | $97 |
| Amlodipine Besylate | 99 | $1,102 | $11 |
| Synthroid | 17 | $955 | $56 |
| Diltiazem Er | 12 | $931 | $78 |
| Valsartan-Hydrochlorothiazide | 15 | $632 | $42 |
| Simvastatin | 93 | $580 | $6 |
| Zolpidem | 83 | $556 | $7 |
| Losartan | 34 | $529 | $16 |
| Metformin | 43 | $456 | $11 |
| Mexiletine | 16 | $399 | $25 |
| Sertraline | 23 | $364 | $16 |
| Hydrochlorothiazide | 51 | $357 | $7 |
| Atenolol | 56 | $354 | $6 |
| Fluticasone Propionate | 23 | $326 | $14 |
| Warfarin | 23 | $316 | $14 |
| Quinapril | 13 | $291 | $22 |
| Alendronate | 14 | $289 | $21 |
| Nitrofurantoin Mono-Macro | 13 | $285 | $22 |
| Triamterene-Hydrochlorothiazid | 28 | $277 | $10 |
| Terazosin | 15 | $247 | $16 |
| Lisinopril-Hydrochlorothiazide | 24 | $236 | $10 |
| Glipizide Xl | 13 | $232 | $18 |
| Clopidogrel | 17 | $208 | $12 |
| Furosemide | 25 | $200 | $8 |
| Allopurinol | 32 | $199 | $6 |
| Pantoprazole | 20 | $197 | $10 |
| Diltiazem 24hr Cd | 15 | $169 | $11 |
| Spironolactone | 14 | $140 | $10 |
| Lovastatin | 14 | $135 | $10 |
| Azithromycin | 18 | $134 | $7 |
| Hydrocodone-Acetaminophen | 11 | $109 | $10 |
| Escitalopram | 15 | $109 | $7 |
| Finasteride | 12 | $85 | $7 |
| Ciprofloxacin | 18 | $80 | $4 |
2013: 43 drugs
| Diovan | 51 | $11,460 | $225 |
| Crestor | 29 | $7,482 | $258 |
| Nexium | 16 | $7,142 | $446 |
| Atorvastatin | 134 | $4,204 | $31 |
| Pradaxa | 11 | $2,919 | $265 |
| Omeprazole | 51 | $2,852 | $56 |
| Lipitor | 12 | $2,792 | $233 |
| Rivastigmine | 11 | $2,503 | $228 |
| Metoprolol | 60 | $2,446 | $41 |
| Cymbalta | 11 | $2,376 | $216 |
| Levothyroxine | 181 | $2,085 | $12 |
| Amlodipine Besylate | 93 | $1,316 | $14 |
| Norvasc | 12 | $1,060 | $88 |
| Lisinopril | 111 | $952 | $9 |
| Pravastatin | 36 | $900 | $25 |
| Gabapentin | 12 | $843 | $70 |
| Metformin | 55 | $788 | $14 |
| Losartan | 36 | $764 | $21 |
| Simvastatin | 77 | $534 | $7 |
| Mexiletine | 12 | $529 | $44 |
| Quinapril | 14 | $510 | $36 |
| Escitalopram | 14 | $489 | $35 |
| Fluticasone Propionate | 16 | $421 | $26 |
| Zolpidem | 63 | $402 | $6 |
| Cartia Xt | 18 | $401 | $22 |
| Finasteride | 21 | $329 | $16 |
| Sertraline | 21 | $328 | $16 |
| Lisinopril-Hydrochlorothiazide | 25 | $318 | $13 |
| Hydrochlorothiazide | 53 | $313 | $6 |
| Atenolol | 43 | $289 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $270 | $25 |
| Warfarin | 22 | $252 | $11 |
| Triamterene-Hctz | 21 | $247 | $12 |
| Tamsulosin | 12 | $215 | $18 |
| Lovastatin | 20 | $203 | $10 |
| Allopurinol | 32 | $189 | $6 |
| Pantoprazole | 16 | $180 | $11 |
| Azithromycin | 17 | $166 | $10 |
| Clopidogrel | 12 | $160 | $13 |
| Glipizide Er | 11 | $151 | $14 |
| Furosemide | 20 | $117 | $6 |
| Hydrocodone-Acetaminophen | 28 | $108 | $4 |
| Ciprofloxacin | 12 | $48 | $4 |
Money from drug and device companies
$17 in 2024
A payment is not proof that care is biased.
| Pfizer | Myfembree | $17 | 1 payment
|
See the published payment
| Pfizer | Education · 2024-05-08 | Myfembree | $17 |
Professional record
- NPI
- 1437114006
- Licence
- CA G73336California G73336: Current · expires 2027-10-31
- Trained
- University of California, San Francisco School of Medicine, 1990
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1300 Crane St, Menlo Park, CA, 94025
- NPI first listed
- 2006-04-18
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: Po Box 60000, San Francisco, CA, 94160